Skip to content

Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial

CHOosing the rIght paCing Mode in Heart failurE : Should Heart Failure Patients With Bradycardia Receive Biventricular Pacemakers Rather Than Conventional Pacemakers?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00875732
Acronym
CHOICE
Enrollment
22
Registered
2009-04-03
Start date
2009-09-30
Completion date
2011-01-31
Last updated
2017-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Resynchronization, Device, Bradycardia, atrioventricular block, Cardiac Resynchronization

Brief summary

The aim of the study is to see if biventricular pacemakers offer any advantage over conventional pacemakers in patients with heart failure who require pacemakers. The endpoints will be the 6 minute walking distance along with markers of cardiovascular function. The investigators' hypothesis is that biventricular pacing is preferable to conventional pacing in these heart failure patients.

Interventions

DEVICEBi Ventricular Pacing
DEVICERight Ventricular Pacing

Sponsors

Chest, Heart and Stroke Association Scotland
CollaboratorOTHER
Abbott Medical Devices
CollaboratorINDUSTRY
University of Dundee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Left ventricular systolic dysfunction. 2. Atrio-ventricular node disease. 3. Anticipated to be more than 40% paced, (including patients in permanent atrial fibrillation). 4. Ability to walk independently (walking aid permitted).

Exclusion criteria

1. Patients meeting criteria for CRT by current guidelines will be excluded. 2. Life expectancy less than12 months. 3. Inability to walk independently. 4. Patients not likely to be compliant with follow-up. 5. Bradyarrhythmia due with sino-atrial disease only.

Design outcomes

Primary

MeasureTime frame
6 minute hall walk testBaseline, 3, 6, 9 and 12 months

Secondary

MeasureTime frame
Endothelial FunctionBaseline, 3, 6, 9 and 12 months
Cardiac OutputBaseline, 3, 6, 9 and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026